Glaukos (GKOS) Cash & Equivalents (2014 - 2026)

Glaukos (GKOS) has 13 years of Cash & Equivalents data on file, last reported at $104.2 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 8.76% year-over-year to $104.2 million in Q1 2026; TTM through Mar 2026 was $104.2 million, a 8.76% decrease from a year earlier, with the FY2025 full-year figure at $90.8 million, down 46.46% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $104.2 million, up from $90.8 million in the prior quarter.
• Over the last five years, Cash & Equivalents for GKOS reached as high as $169.6 million in Q4 2024 and fell as low as $42.5 million in Q1 2024.
• Historically, Cash & Equivalents has averaged $99.7 million across 5 years, with a median of $100.8 million in 2025.
• On a YoY basis, Cash & Equivalents climbed as much as 168.86% in 2025 and fell as far as 46.46% in 2025.
• Year by year, Cash & Equivalents stood at $119.5 million in 2022, then retreated by 21.8% to $93.5 million in 2023, then jumped by 81.48% to $169.6 million in 2024, then sank by 46.46% to $90.8 million in 2025, then increased by 14.8% to $104.2 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $104.2 million in Q1 2026, $90.8 million in Q4 2025, and $98.2 million in Q3 2025.